How dialysis affects blood clotting in kidney patients
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial looks at how hemodialysis changes blood clotting in dialysis patients. It may help doctors understand why some people form clots and how to prevent them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a dialysis patient who has been on regular dialysis for at least 3 months.
- You are an adult (18 to 85 years old) and healthy, with no major diseases like diabetes, heart disease, or cancer.
- You have a confirmed blood clot (thrombosis) seen on an ultrasound or CT scan, and your D-dimer level is high.
- You are not taking blood-thinning medications like heparin that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two strategies for managing atrial fibrillation (irregular heartbeat) in people on dialysis: one uses a blood thinner called apixaban to prevent strokes, and the other does not. The goal is to find out which approach is safer and more effective for this specific group.
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
This trial studies whether the blood thinner warfarin is safe and effective for preventing stroke and blood clots in people who have atrial fibrillation and need long-term dialysis. It may help your care team better balance clot prevention against bleeding risk.
This trial tests three experimental antibodies given to people with end-stage kidney disease who are on hemodialysis. It aims to see if these drugs are safe and how they affect blood clotting in this group.
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
This study looks at whether two simple blood tests (D-dimer and CRP) can help predict heart problems in people on dialysis. If you join, they would check these markers in your blood and see if they relate to your heart health.
Hear when a new Dialysis Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.